MaxLinear's stock price surged 5.15% during the night session, marking a significant recovery movement.

The rally is primarily driven by a technical rebound following multiple rounds of correction since mid-May, as profit-taking had previously led to substantial selling pressure. Fundamentally, the company's strong first-quarter earnings provided key support, with net revenue reaching $137.2 million, representing 43% year-over-year growth, a return to profitability, and raised second-quarter revenue guidance to $160-170 million.

Additionally, institutional confidence was bolstered by Vanguard Portfolio Management increasing its stake in MaxLinear to 10.23%, signaling positive medium-to-long-term outlook for the company.